Status:

UNKNOWN

Venoarterial PCO2 Difference /Arteriovenous O2 Content Difference Ratio as Goal of Early Septic Shock Therapy

Lead Sponsor:

Peking Union Medical College Hospital

Conditions:

Septic Shock

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Reducing tissue hypoxia is the ultimate goal of severe sepsis and septic shock therapy.Venoarterial PCO2 difference /arteriovenous O2 content difference ratio (△PCO2/Ca-vO2) is considered to be a good...

Eligibility Criteria

Inclusion

  • severe sepsis and septic shock patients

Exclusion

  • \<18 years old
  • pregnant and breast-feed woman
  • AMI
  • cerebral hemorrhage
  • contraindication for central venous catheter or arterial catheter;
  • brainstem death

Key Trial Info

Start Date :

June 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT01877798

Start Date

June 1 2013

Last Update

June 14 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Peking Union Medical College Hospital critical care medicine

Beijing, China

Venoarterial PCO2 Difference /Arteriovenous O2 Content Difference Ratio as Goal of Early Septic Shock Therapy | DecenTrialz